The lipidomics reporting checklist a framework for transparency of lipidomic experiments and repurposing resource data

Affiliations

• ¹ Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
• ² Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences, University of Southern Denmark, Odense, Denmark; Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
• ³ Center for Human Nutrition and Department of Molecular Genetics, UT Southwestern Medical Center, Dallas, Texas, USA.
• ⁴ Division of Metabolomics/Mass Spectrometry Center, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
• ⁵ Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
• ⁶ MetaboHUB-Metatoul, National Infrastructure of Metabolomics and Fluxomics, Inserm I2MC, Toulouse, France.
• ⁷ Heidelberg University Biochemistry Center (BZH), University of Heidelberg, Heidelberg, Germany.
• ⁸ Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
• ⁹ Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
• ¹⁰ Swansea University Medical School, Swansea, Wales, UK.
• ¹¹ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
• ¹² Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
• ¹³ Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Regensburg, Germany.
• ¹⁴ Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic.
• ¹⁵ Institute for Bio- and Geosciences (IBG-5), Forschungszentrum Jülich GmbH, Jülich, Germany.
• ¹⁶ Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Cardiovascular Research Translation and Implementation, La Trobe University, Bundoora, VIC, Australia.
• ¹⁷ Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany.
• ¹⁸ Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA.
• ¹⁹ Department of Psychiatry and Behavioural Sciences, Duke University, Durham, North Carolina, USA; Duke Institute of Brain Sciences, Duke University, Durham, North Carolina, USA; Department of Medicine, Duke University, Durham, North Carolina, USA.
• ²⁰ Core Facility Mass Spectrometry and Lipidomics, ZMF, Medical University of Graz, Graz, Austria.
• ²¹ Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.
• ²² Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, UK.
• ²³ Laboratory of Biomedical and Analytical Sciences, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan.
• ²⁴ Division of Bioanalytical Chemistry, Research Center Borstel - Leibniz Lung Center, Borstel, Germany; German Center for Infection Research, Thematic Translational Unit Tuberculosis, Partner Site Hamburg-Lübeck-Borstel-Riems, Germany; German Center for Lung Research (DZL), Airway Research Center North (ARCN), Borstel, Germany.
• ²⁵ Max-Planck-Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
• ²⁶ Singapore Lipidomics Incubator (SLING), Department of Biochemistry, YLL School of Medicine, National University of Singapore, Singapore, Singapore; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, Singapore.
• ²⁷ European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
• ²⁸ Kansas Lipidomics Research Center, Division of Biology, Kansas State University, Manhattan, Kansas, USA.
• ²⁹ Singapore Lipidomics Incubator (SLING), Department of Biochemistry, YLL School of Medicine, National University of Singapore, Singapore, Singapore.
• ³⁰ MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, China.
• ³¹ Lipidomics Consulting Ltd., Esbo, Finland. Electronic address: [email protected].
• ³² Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria. Electronic address: [email protected].
• ³³ Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Regensburg, Germany. Electronic address: [email protected].